Indication
Catamenial Epilepsy
2 clinical trials
2 products
Clinical trial
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Subjects With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.Status: Completed, Estimated PCD: 2008-10-01
Product
GanaxoloneClinical trial
Pilot Study of Add-On Fycompa (Perampanel)Treatment for Catamenial EpilepsyStatus: Recruiting, Estimated PCD: 2023-12-15
Product
Fycompa